Zhang Haobin, Qin Si, Zhang Lei, Feng Zhuxiao, Fan Changhe
The Big Data Institute, Guangdong Create Environmental Technology Company Limited, Guangzhou, China.
Department of Dermatology, Guangdong Second Provincial General Hospital, Guangzhou, China.
Ann Transl Med. 2020 Aug;8(15):941. doi: 10.21037/atm-20-4907.
This study investigated the depression, anxiety, and insomnia levels of coronavirus disease 2019 (COVID-19) patients admitted to two mobile cabin hospitals in Jianghan District (Wuhan, China).
Thirty COVID-19 (eight mild type and twenty-two common type) patients were evaluated using the Patient Health Questionnaire-9, the Generalized Anxiety Disorder 7 Questionnaire, the Insomnia Severity Index, and a semi-structured interview.
All 30 patients reported varying degrees of anxiety, depression, and insomnia. The levels of depression and anxiety in mild type COVID-19 patients were significantly lower than those in common type COVID-19 patients. Significant improvements in depression (P<0.001) and anxiety (P<0.001) levels were found in the COVID-19 patients at the second evaluation compared with the baseline (admittance to hospital). More than 80% patients agreed that medical security, support from other patients, and a better living environment were the main reasons for improvements to their adverse psychological states.
Varying degrees of anxiety, depression, and insomnia frequently occur in patients with COVID-19. Standard treatment protocols and patient-centered care in the mobile cabin hospitals in this study provided the chance for COVID-19 patients to successfully improve their mental health during the outbreak of the pandemic.
本研究调查了武汉市江汉区两家方舱医院收治的新型冠状病毒肺炎(COVID-19)患者的抑郁、焦虑和失眠水平。
采用患者健康问卷-9、广泛性焦虑障碍7项问卷、失眠严重程度指数及半结构化访谈对30例COVID-19患者(8例轻型和22例普通型)进行评估。
30例患者均报告有不同程度的焦虑、抑郁和失眠。轻型COVID-19患者的抑郁和焦虑水平显著低于普通型COVID-19患者。与基线(入院时)相比,COVID-19患者在第二次评估时抑郁(P<0.001)和焦虑(P<0.001)水平有显著改善。超过80%的患者认为医疗保障、其他患者的支持和更好的生活环境是其不良心理状态改善的主要原因。
COVID-19患者常出现不同程度的焦虑、抑郁和失眠。本研究中方舱医院的标准化治疗方案和以患者为中心的护理为COVID-19患者在疫情暴发期间成功改善心理健康提供了机会。